WWC1 and Alzheimer disease: The potential mechanisms by which KIBRA contributes to synaptic plasticity, and AD progression warrant further investigation, including the potential impact on Aβ-amyloid accumulation, and may reveal novel pathways contributing to neuroprotection/neurodegeneration.